Production and Marketing Administration

U. S. Dept. Agr., Production and Marketing Administration, Interpretations of Regulations for... 

In one procedure that has been widely used, the sample, after suitable treatment, is refluxed with sodium and isopropyl alcohol, after which the solution is diluted with water and the inorganic chloride is determined by standard methods (13, 54) The method has been adopted by the Association of Official Agricultural Chemists 29, 30) as a tentative one for technical DDT and for dusts, oil solutions, and aqueous emulsions of DDT, for use in the absence of other chlorine-containing compounds. The National Association of Insecticide and Disinfectant Manufacturers has also accepted the total-chlorine method for the analysis of these preparations 28). Essentially the same procedures have been described by Donovan 22), of the Insecticide Division of the Production and Marketing Administration, for technical DDT and various commercial DDT products containing no other compounds interfering with the chlorine determination. 

A number of official samples have been analyzed in the insecticide laboratory of the Production and Marketing Administration, which contained among the active ingredients 7-benzene hexachloride, DDT, and sulfur in the proportions of 3, 5, and 57%, respectively. The following detailed procedure was adopted after testing with authentic formulations of this type. 

The Production and Marketing Administration of the Department of Agriculture released a comprehensive report in the summer of 1950 entitled World Trends in Supply, Distribution and Prices of Naval Stores, 1934-1949, which is a valuable addition to naval stores statistical material. 

Production and Marketing Administration of the U. S. Department of Agriculture, Washington 25, D. C. 

Production and Marketing Administration, Sugar Reports, Molasses Issue, annual, 1948-. Supply and utilization of ethyl alcohol. 

Production and Marketing Administration, Tbe Fertilizer Situation, annual, 1943-Current and historical data on production, supply and use of fertilizers. 

Represents over 95% of deliveries by primary distributors in continental United States. Data from Production and Marketing Administration, USD A. 

In a survey reported by the U. S. Production and Marketing Administration in 1951 (3) frozen food processors indicated that one of the principal advantages of dry sweetened packs is their general adaptability to any sort of commercial or household end use. For this reason, many smaller firms specializing in only one type of pack generally prefer to use dry sweeteners. 

The Production and Marketing Administration of the United States Department of Agriculture promulgated standards of identity, including color specifications based on the Munsell system for tomato pulp (pur e), juice, paste, and catsup. We shall consider the specifications for pulp, the grade of which is determined by a numerical point score, 60 for color and 40 for absence of defects. (The color score for catsup is only 25% and for juice, 30% of the total score.) The appropriate section of the specification is quoted below ... 

The cost of subsidizing fuels is also large. The level of administrative costs depends on how the program is implemented. In most cases, when countries are not involved in processing petroleum products and marketing operations, administrative costs are relatively small. 

The Bureau of Pharmaceutical Affairs of the Ministry of Health and Social Affairs (MOHS A) and the Korean Food and Drug Administration (KFDA) are the agencies responsible for the laws ruling cosmetic production and marketing in Republic of Korea (ROK). The Cosmetic Law, which came into force on 1 July 2000, is the reference text and it identifies two categories of cosmetics cosmetics as such and functional cosmetics or cosmeceuticals. 

Claims for oral dental riases are regulated by the Food and Dmg Administration whether they are marketed as dmgs or cosmetics. The Council on Dental Therapeutics of the American Dental Association reviews oral riases, and may authori2e use of the Seal of Acceptance for a product. 

Products now marketed in Europe and Asia attain approved status by the U.S. Food and Drug Administration (FDA) and enter the huge and (ucrative American market. 

The approved color additives appear on positive lists issued by the Food and Drug Administration in the US, the EU, and Japan, but the colorants permitted in each market vary considerably. US and EU regulatory organizations provide provisional and permanent lists of approved color additives. The permanently listed additives are considered safe for use in cosmetic and toiletry products by the regulatory bodies. Provisionally listed color additives are those on which some safety studies are still to be undertaken or their test results are under review. The Japanese regulations include only a permanent list of color additives. 

CAC instruments use to be compared with MB instruments that are characterized by a private administration and enforcement system and stimulate indirectly the behavior of the firm. There are essentially two different types of those instruments taxes that are fees imposed on emitters proportionate to the total amount of emissions released into the environment (they could be divided into emission charges, product charges, and user charges) and marketable (or tradable) permit systems that provide a fixed number of permits equal to the allowed total emissions, distributing them among polluting firms in a specific area. 

After the approval of the first product, recombinant insulin, in 1982, progress in the development of new recombinant protein pharmaceuticals was slow ([10], Fig. 17.1). The number of biotechnology-derived drugs and vaccines approved by the US Food and Dmg Administration (FDA) has increased significantly only since 1995. More recently, sales of biologies have skyrocketed, e.g. from 900 million in 1999 to an estimated 3.5 billion in 2001 for monoclonal antibodies [11]. The annual global market for biopharmaceuticals is estimated to have increased from 12 billion US to 30 billion US in 2003 [12]. 500 candidate biopharmaceuticals are undergoing clinical evaluation and over one hundred protein-based therapeutics are in the... 

---